Track the companies of Group.
| Sales Growth | Profit Growth | Expense Growth | Stock Price CAGR |
|---|---|---|---|
Presentation & Earning Calls |
Annual Reports |
Credit Rating |
|---|---|---|
|
|
|
|
Zydus Lifesciences (Formerly known as Cadila Healthcare), a leading Indian Pharmaceutical company is a fully integrated, global healthcare provider. With in-depth domain expertise in the field of healthcare, it has strong capabilities across the spectrum of the pharmaceutical value chain. From formulations to active pharmaceutical ingredients and animal healthcare products to wellness products, Zydus has earned a reputation amongst Indian pharmaceutical companies for providing comprehensive and complete healthcare solutions.
The company provides pathbreaking and life-changing therapies that address unmet medical needs and enhance quality of life by supporting wellness and better health - whether through disease prevention, early detection, or effective management. With a focus on optimizing access and delivery, Zydus aims to revolutionize healthcare for the future. The company continues to unlock new possibilities in lifesciences through novel drug discoveries.
The company is fully committed to and continuously endeavors to achieve environment, health and safety excellence across all the units. The Company continues to invest substantial resources towards sustaining and continuously improving the standards of environment, occupational health and safety as it believes that its responsibility towards the society and the environment extends beyond those laid down by the regulatory authorities. The Company integrates sustainability deeply into its research and development (R&D) strategy, ensuring long-term impact and global health advancement. The Company’s R&D initiatives span across areas such as novel drug discovery, biosimilars, vaccines, specialty products and new dosage form development.
The company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products. The company is committed to deliver high quality, affordable medicines to the patients by leveraging the best contemporary technology and process improvements.
Business verticals / products
Awards
2008-09:
2009-10:
2010-11:
2011-12:
2012-13:
2013-14:
2014-15:
2015-16:
2016-17:
2017-18:
2018-19:
2019-20:
Comment